Stay updated on Pembrolizumab Combo with Chemo in Advanced Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo with Chemo in Advanced Colorectal Cancer Clinical Trial page.

Latest updates to the Pembrolizumab Combo with Chemo in Advanced Colorectal Cancer Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe record for the pembrolizumab plus chemotherapy study in advanced colorectal cancer is displayed, including its design, eligibility criteria, participating locations, and outcome measures. It also shows that the study is completed and no longer recruiting.SummaryDifference52%

- Check14 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check21 days agoChange DetectedA notice appears above the study record announcing an NIH transition from “Artificial Intelligence” to “Super Intelligence” terminology and linking to updates and FAQs.SummaryDifference1%

- Check28 days agoChange DetectedThe footer’s site revision label changed from v3.7.1 to v3.7.2, while the 403 error page remained otherwise unchanged.SummaryDifference0.2%

- Check35 days agoChange DetectedThe site revision label in the footer changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check56 days agoChange DetectedRevision: v3.7.0 was added to the page. A large set of investigator, sponsor, collaborator, and related study metadata were removed, altering the visible core details of the study record.SummaryDifference19%

Stay in the know with updates to Pembrolizumab Combo with Chemo in Advanced Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo with Chemo in Advanced Colorectal Cancer Clinical Trial page.